Form 8-K Shire plc For: Apr 18

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 18, 2018

 

SHIRE PLC

(Exact name of registrant as specified in its charter)

 

Jersey, Channel Islands	0-29630	98-0601486
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

Block 2

Miesian Plaza

50-58 Baggot Street Lower

Dublin 2

Republic of Ireland
(Address of principal executive offices)

 

Registrant’s telephone number, including area code:    +353 1 609 6000

 

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 8.01. Other Events

 

Shire plc has issued the press releases attached hereto as Exhibit 99.1 and 99.2 which are incorporated by reference herein.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits. The following exhibits are filed herewith:

 

99.1       Press Release dated April 18, 2018

 

99.2       Press Release dated April 18, 2018

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press Release dated April 18, 2018
99.2		Press Release dated April 18, 2018

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Shire plc
By:	/s/ W R Mordan
	Name:	Bill Mordan
	Title:	Company Secretary

Date: April 18, 2018

 

 

Exhibit 99.1

 

Press Release
www.shire.com

 

Shire to announce first quarter 2018 results

 

Dublin, Ireland – April 18, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG), will announce first quarter 2018 earnings on Thursday April 26, 2018.

 

Results press release will be issued at:	12:00 BST / 07:00 EDT
Investor conference call time:	14:00 BST / 09:00 EDT

 

Live conference call for investors: 

Flemming Ornskov, MD, M.P.H., Chief Executive Officer and Thomas Dittrich, Chief Financial Officer will host the investor and analyst conference call at 9:00 am EDT / 14:00 BST.

 

The details of the conference call are as follows: 

UK dial in:	0800 358 9473 or +44 333 300 0804
US dial in:	1 855 857 0686 or 1 631 913 1422
International Access Numbers:	Click here
Password/Conf ID:	83293759 #
Live Webcast:	Click here

 

Replay: 

A replay of the presentation will be available for two weeks by phone and by webcast for three months. Replay information can be found on the Investor Relations section of Shire’s website at http://investors.shire.com/.

 

For further information please contact:

 

Investor Relations
Christoph Brackmann	[email protected]	+41 795 432 359
Sun Kim	[email protected]	+1 617 588 8175
Robert Coates	[email protected]	+44 203 549 0874
Media
Katie Joyce	[email protected]	+1 781 482 2779

 

About Shire

 

Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

 

We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them on their journey.

 

www.shire.com

 

 

 

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

 

Exhibit 99.2

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

18 April 2018

 

Shire plc (“Shire” or the “Company”)

 

Rule 2.9 Announcement

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 17 April 2018, being the last business day prior to the date of this announcement, it had 919,649,267 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting rights in Shire is 912,291,984. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

 

Shire has an American Depositary Share (“ADS”) programme for which Citibank, N.A. acts as depositary. One ADS represents three ordinary shares of 5 pence each, with ISIN US2481R1068. The ADSs trade on the NASDAQ Global Select Market.

 

Enquiries:

 

Shire plc

 

Christoph Brackmann (Investor Relations)	+41 795 432 359
Sun Kim (Investor Relations)	+1 617 588 8175
Katie Joyce (Media)	+1 781 482 2779

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Faron Confirms Plans for the Coming Months Under New Leadership
• Microex Launches Web3.0 Financial Trading Solution - Pioneering Innovation in Financial Technology
• InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 16